Recombinant monoclonal antibody to CD44. 1A9.A6.B9 is a human antibody that can be potentially used in the treatment of inflammatory disease and autoimmune disease.
Figure 1 is a graph illustrating the anti-CD44 1A9.A6.B9 antibody blocking the binding of HA to the CD44-lg fusion protein.
Figure 2 is a graph illustrating binding of anti-CD44 1A9.A6.B9 and 14G9.B8.B4 antibodies to human whole blood T-cells as assayed by FACS.
Figure 3 is a graph illustrating the binding study of anti-CD44 1A9.A6.B9 antibody using human and cyno CD44-lg fusion proteins as measured by ELISA assays.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-727 | Anti-CD44 Recombinant Antibody (Bivatuzumab) | ELISA, FC, IP, FuncS, IF, Neut, ICC | IgG1 |
TAB-236LC | Anti-Human CD44 Recombinant Antibody (huPTA-4621) | FuncS | Humanized antibody |
TAB-236LC-S(P) | Anti-Human CD44 Recombinant Antibody scFv Fragment (huPTA-4621) | FC | Humanized antibody |
TAB-236LC-F(E) | Anti-Human CD44 Recombinant Antibody Fab Fragment (huPTA-4621) | FC | Humanized antibody |
There are currently no Customer reviews or questions for TAB-227LC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.